QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)
QQQ   420.00 (-0.81%)
AAPL   165.05 (-1.19%)
MSFT   400.63 (-0.90%)
META   489.80 (-2.39%)
GOOGL   154.71 (-0.83%)
AMZN   176.83 (-1.33%)
TSLA   150.24 (+0.21%)
NVDA   824.57 (-2.61%)
AMD   151.95 (-2.02%)
NIO   3.89 (-2.75%)
BABA   68.78 (-0.15%)
T   16.40 (+0.43%)
F   12.15 (+0.75%)
MU   110.33 (-1.43%)
GE   151.63 (-0.86%)
CGC   8.04 (+2.68%)
DIS   111.91 (-0.46%)
AMC   3.15 (+7.88%)
PFE   25.55 (+0.63%)
PYPL   61.98 (-0.19%)
XOM   120.66 (+1.81%)

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$107.26
+1.9%
$114.28
$89.67
$121.64
$186.12B0.745.64 million shs1.41 million shs
Medtronic plc stock logo
MDT
Medtronic
$79.41
+0.3%
$84.04
$68.84
$92.02
$105.44B0.766.24 million shs884,786 shs
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$500.66
+1.5%
$488.97
$436.38
$554.70
$461.57B0.544.48 million shs1.54 million shs
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Abbott Laboratories stock logo
ABT
Abbott Laboratories
-0.59%-5.52%-6.94%-8.26%-6.25%
Medtronic plc stock logo
MDT
Medtronic
+0.14%-3.61%-5.87%-8.43%-6.69%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
+2.96%+11.65%-0.03%-1.81%+1.43%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Abbott Laboratories stock logo
ABT
Abbott Laboratories
4.9943 of 5 stars
3.45.04.24.53.12.52.5
Medtronic plc stock logo
MDT
Medtronic
4.5009 of 5 stars
2.23.03.34.12.72.51.9
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
4.9597 of 5 stars
3.43.04.24.03.12.52.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Abbott Laboratories stock logo
ABT
Abbott Laboratories
2.75
Moderate Buy$121.3113.10% Upside
Medtronic plc stock logo
MDT
Medtronic
2.45
Hold$94.9119.52% Upside
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
2.82
Moderate Buy$570.0513.86% Upside

Current Analyst Ratings

Latest UNH, MDT, and ABT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/19/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$545.00 ➝ $562.00
4/18/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$128.00 ➝ $125.00
4/17/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$566.00 ➝ $571.00
4/17/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$534.00 ➝ $560.00
4/17/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$596.00 ➝ $555.00
4/17/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$600.00
4/10/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$607.00 ➝ $546.00
4/10/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$591.00
4/8/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$600.00 ➝ $525.00
4/5/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOverweight ➝ Overweight$618.00 ➝ $584.00
4/4/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$120.00 ➝ $125.00
(Data available from 4/19/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$40.11B4.64$6.44 per share16.65$22.36 per share4.80
Medtronic plc stock logo
MDT
Medtronic
$31.23B3.38$7.35 per share10.80$38.83 per share2.05
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$371.62B1.24$31.12 per share16.09$100.19 per share5.00

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$5.72B$3.2133.4120.872.5513.96%20.32%10.59%7/18/2024 (Estimated)
Medtronic plc stock logo
MDT
Medtronic
$3.76B$3.1425.2914.542.7113.00%13.71%7.81%5/23/2024 (Estimated)
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$22.38B$16.3630.6016.061.314.05%26.50%8.60%7/12/2024 (Estimated)

Latest UNH, MDT, and ABT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/17/2024Q1 24
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$0.96$0.98+$0.02$1.26$9.88 billion$9.96 billion    
4/16/2024Q1 24
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$6.63$6.91+$0.28$15.35$99.23 billion$99.80 billion    
2/20/202401/31/2024
Medtronic plc stock logo
MDT
Medtronic
$1.26$1.30+$0.04$1.61$7.95 billion$8.09 billion    
1/24/202412/31/2023
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$1.19$1.19N/A$1.47$10.19 billion$10.24 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Abbott Laboratories stock logo
ABT
Abbott Laboratories
$2.202.05%+12.31%68.54%53 Years
Medtronic plc stock logo
MDT
Medtronic
$2.763.48%+6.45%87.90%47 Years
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
$7.521.50%+14.71%45.97%14 Years

Latest UNH, MDT, and ABT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/16/2024
Abbott Laboratories stock logo
ABT
Abbott Laboratories
quarterly$0.551.9%4/12/20244/15/20245/15/2024
3/7/2024
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.693.24%3/21/20243/22/20244/12/2024
2/23/2024
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
quarterly$1.881.43%3/8/20243/11/20243/19/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Abbott Laboratories stock logo
ABT
Abbott Laboratories
0.35
1.64
1.16
Medtronic plc stock logo
MDT
Medtronic
0.46
2.30
1.71
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.69
0.85
0.79

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
75.18%
Medtronic plc stock logo
MDT
Medtronic
82.06%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
87.86%

Insider Ownership

CompanyInsider Ownership
Abbott Laboratories stock logo
ABT
Abbott Laboratories
1.10%
Medtronic plc stock logo
MDT
Medtronic
0.30%
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
0.35%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Abbott Laboratories stock logo
ABT
Abbott Laboratories
114,0001.74 billion1.72 billionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.33 billion1.32 billionOptionable
UnitedHealth Group Incorporated stock logo
UNH
UnitedHealth Group
440,000921.93 million918.71 millionOptionable

UNH, MDT, and ABT Headlines

SourceHeadline
FY2024 EPS Estimates for UnitedHealth Group Incorporated (NYSE:UNH) Raised by AnalystFY2024 EPS Estimates for UnitedHealth Group Incorporated (NYSE:UNH) Raised by Analyst
marketbeat.com - April 19 at 8:50 AM
Federated Hermes Inc. Sells 4,750 Shares of UnitedHealth Group Incorporated (NYSE:UNH)Federated Hermes Inc. Sells 4,750 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - April 19 at 8:27 AM
UnitedHealth Group (NYSE:UNH) PT Raised to $562.00UnitedHealth Group (NYSE:UNH) PT Raised to $562.00
marketbeat.com - April 19 at 8:25 AM
UnitedHealth Group (NYSE:UNH) Price Target Cut to $555.00UnitedHealth Group (NYSE:UNH) Price Target Cut to $555.00
americanbankingnews.com - April 19 at 5:06 AM
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against UnitedHealth Group Incorporated and Encourages Investors with Losses to Contact the FirmIMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against UnitedHealth Group Incorporated and Encourages Investors with Losses to Contact the Firm
accesswire.com - April 19 at 4:00 AM
UnitedHealth Group Incorporated Forecasted to Post Q2 2024 Earnings of $6.84 Per Share (NYSE:UNH)UnitedHealth Group Incorporated Forecasted to Post Q2 2024 Earnings of $6.84 Per Share (NYSE:UNH)
americanbankingnews.com - April 19 at 3:50 AM
UnitedHealth Group (NYSE:UNH) Shares Up 3.8% Following Analyst UpgradeUnitedHealth Group (NYSE:UNH) Shares Up 3.8% Following Analyst Upgrade
americanbankingnews.com - April 19 at 2:40 AM
Truist Financial Reiterates "Buy" Rating for UnitedHealth Group (NYSE:UNH)Truist Financial Reiterates "Buy" Rating for UnitedHealth Group (NYSE:UNH)
americanbankingnews.com - April 19 at 1:58 AM
UnitedHealth Group (NYSE:UNH) Cut to "Hold" at StockNews.comUnitedHealth Group (NYSE:UNH) Cut to "Hold" at StockNews.com
marketbeat.com - April 18 at 11:13 PM
Fidelis Capital Partners LLC Buys 1,669 Shares of UnitedHealth Group Incorporated (NYSE:UNH)Fidelis Capital Partners LLC Buys 1,669 Shares of UnitedHealth Group Incorporated (NYSE:UNH)
marketbeat.com - April 18 at 7:04 PM
Three Stocks: Taiwan Semiconductor, Meta, and UnitedHealthThree Stocks: Taiwan Semiconductor, Meta, and UnitedHealth
moneymorning.com - April 18 at 6:13 PM
UnitedHealth Stock Overtakes Key Level On Earnings And Hospital Trend ChangeUnitedHealth Stock Overtakes Key Level On Earnings And Hospital Trend Change
finance.yahoo.com - April 18 at 6:13 PM
UnitedHealth Reports Processing Issues at Change HealthcareUnitedHealth Reports Processing Issues at Change Healthcare
pymnts.com - April 18 at 4:00 PM
UnitedHealth Group Inc (UNH) Q1 2024 Earnings: Adjusted EPS Beats Estimates Amidst Cyberattack ...UnitedHealth Group Inc (UNH) Q1 2024 Earnings: Adjusted EPS Beats Estimates Amidst Cyberattack ...
gurufocus.com - April 18 at 2:02 PM
UnitedHealth Group: A Loud Sigh Of Relief In Q124UnitedHealth Group: A Loud Sigh Of Relief In Q1'24
seekingalpha.com - April 18 at 1:13 PM
UPDATE 1-UnitedHealth unit Change faces issue processing some medical claimsUPDATE 1-UnitedHealth unit Change faces issue processing some medical claims
finance.yahoo.com - April 18 at 1:13 PM
UnitedHealth Group (NYSE:UNH) Shares Up 3.8% After Analyst UpgradeUnitedHealth Group (NYSE:UNH) Shares Up 3.8% After Analyst Upgrade
marketbeat.com - April 18 at 11:42 AM
Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.Want to Double Your Tax Refund in 2024? 7 Stocks to Buy Now.
investorplace.com - April 18 at 10:23 AM
UnitedHealth unit Change Healthcare faces issue processing some medical claimsUnitedHealth unit Change Healthcare faces issue processing some medical claims
reuters.com - April 18 at 10:00 AM
UnitedHealth’s Financial Resilience Drives Buy Rating Amidst ChallengesUnitedHealth’s Financial Resilience Drives Buy Rating Amidst Challenges
markets.businessinsider.com - April 18 at 8:13 AM
Research Analysts Offer Predictions for UnitedHealth Group Incorporateds Q2 2024 Earnings (NYSE:UNH)Research Analysts Offer Predictions for UnitedHealth Group Incorporated's Q2 2024 Earnings (NYSE:UNH)
marketbeat.com - April 18 at 5:59 AM
UnitedHealth Group (NYSE:UNH) Price Target Raised to $571.00 at Piper SandlerUnitedHealth Group (NYSE:UNH) Price Target Raised to $571.00 at Piper Sandler
americanbankingnews.com - April 18 at 5:56 AM
UnitedHealth Group (NYSE:UNH) Price Target Increased to $560.00 by Analysts at BarclaysUnitedHealth Group (NYSE:UNH) Price Target Increased to $560.00 by Analysts at Barclays
americanbankingnews.com - April 18 at 5:56 AM
UnitedHealth Group (NYSE:UNH) Shares Up 5.2% on Strong EarningsUnitedHealth Group (NYSE:UNH) Shares Up 5.2% on Strong Earnings
americanbankingnews.com - April 18 at 1:44 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

Abbott Laboratories logo

Abbott Laboratories

NYSE:ABT
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.
Medtronic logo

Medtronic

NYSE:MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.
UnitedHealth Group logo

UnitedHealth Group

NYSE:UNH
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage. The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities. The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, governments, life sciences companies, and other organizations. The Optum Rx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and community health pharmacy services, infusion, and purchasing and clinical capabilities, as well as develops programs in the areas of step therapy, formulary management, drug adherence, and disease/drug therapy management. UnitedHealth Group Incorporated was founded in 1974 and is based in Minnetonka, Minnesota.